메뉴 건너뛰기




Volumn 31, Issue 4, 2005, Pages 476-481

Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?

Author keywords

Adhesion; Antiplatelet medications; Monitoring; Platelets

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 9; CITRIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN; GLYCOPROTEIN IB; POLYMER; TIROFIBAN;

EID: 25444461992     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916684     Document Type: Conference Paper
Times cited : (5)

References (12)
  • 1
    • 0032534833 scopus 로고    scopus 로고
    • The Xylum Clot Signature Analyzer: A dynamic flow system that simulates vascular injury
    • Li CK, Hoffmann TJ, Hsieh PY, Malik S, Watson WC. The Xylum Clot Signature Analyzer: a dynamic flow system that simulates vascular injury. Thromb Res 1998;92:S66-S77
    • (1998) Thromb Res , vol.92
    • Li, C.K.1    Hoffmann, T.J.2    Hsieh, P.Y.3    Malik, S.4    Watson, W.C.5
  • 2
    • 0034932818 scopus 로고    scopus 로고
    • Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors
    • Lakkis NM, George S, Thomas E, Ali M, Guyer K, Carville D. Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors. Catheter Cardiovasc Interv 2001;53:346-351
    • (2001) Catheter Cardiovasc Interv , vol.53 , pp. 346-351
    • Lakkis, N.M.1    George, S.2    Thomas, E.3    Ali, M.4    Guyer, K.5    Carville, D.6
  • 3
    • 0035147041 scopus 로고    scopus 로고
    • Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention
    • Madan M, Berkowitz SD, Christie DJ, et al. Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention. Am Heart J 2001;141:226-233
    • (2001) Am Heart J , vol.141 , pp. 226-233
    • Madan, M.1    Berkowitz, S.D.2    Christie, D.J.3
  • 4
    • 0033537494 scopus 로고    scopus 로고
    • Rapid platelet-function assay: An automated and quantitative cartridge-based method
    • Smith JW, Steinhubl SR, Lincoff M, et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 1999;99:620-625
    • (1999) Circulation , vol.99 , pp. 620-625
    • Smith, J.W.1    Steinhubl, S.R.2    Lincoff, M.3
  • 5
    • 0031863678 scopus 로고    scopus 로고
    • Cone and plate(let) analyzer: Monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions
    • Varon D, Lashevski I, Brenner B, et al. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am Heart J 1998;135:S187-S193
    • (1998) Am Heart J , vol.135
    • Varon, D.1    Lashevski, I.2    Brenner, B.3
  • 7
    • 0031568828 scopus 로고    scopus 로고
    • A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions
    • Varon D, Dardik R, Shenkman B, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997;85:283-294
    • (1997) Thromb Res , vol.85 , pp. 283-294
    • Varon, D.1    Dardik, R.2    Shenkman, B.3
  • 8
    • 0034918474 scopus 로고    scopus 로고
    • Anti-GPIIb/IIIa drugs: Current strategies and future directions
    • Coller BS. Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost 2001;86:427-443
    • (2001) Thromb Haemost , vol.86 , pp. 427-443
    • Coller, B.S.1
  • 9
    • 0034351986 scopus 로고    scopus 로고
    • Monitoring antiplatelet therapy: What is the best method?
    • Mukherjee D, Moliterno DJ. Monitoring antiplatelet therapy: what is the best method? Clin Pharmacokinet 2000;39:445-458
    • (2000) Clin Pharmacokinet , vol.39 , pp. 445-458
    • Mukherjee, D.1    Moliterno, D.J.2
  • 10
    • 0032901931 scopus 로고    scopus 로고
    • Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: Discriminating abciximab and small molecular weight antagonists
    • Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists. Circulation 1999;99:2231-2238
    • (1999) Circulation , vol.99 , pp. 2231-2238
    • Quinn, M.1    Deering, A.2    Stewart, M.3    Cox, D.4    Foley, B.5    Fitzgerald, D.6
  • 11
    • 0034718512 scopus 로고    scopus 로고
    • Flow cytometric monitoring of glycoprotein Ilb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: Continuous platelet inhibition by the combination of abciximab and ticlopidine
    • Peter K, Kohler B, Straub A. Flow cytometric monitoring of glycoprotein Ilb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine. Circulation 2000;102:1490-1496
    • (2000) Circulation , vol.102 , pp. 1490-1496
    • Peter, K.1    Kohler, B.2    Straub, A.3
  • 12
    • 25444507283 scopus 로고    scopus 로고
    • Sanofi-Synthelabo; Berlin, Germany, September
    • Plavix® 75 mg. Package insert. Sanofi-Synthelabo; Berlin, Germany, September 2002
    • (2002) Plavix® 75 Mg. Package Insert


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.